Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class

J Med Chem. 1986 Oct;29(10):2009-15. doi: 10.1021/jm00160a035.

Abstract

The alpha-ethyl phenethylamine derivative 1-(1,3-benzodioxol-5-yl)-2-butanamine was prepared. An asymmetric synthesis was used to prepare the enantiomers of this compound and the related alpha-methyl homologue (MDA). The racemates and enantiomers of both compounds were evaluated in the two-lever drug discrimination assay in rats trained to discriminate saline from 0.08 mg/kg of LSD tartrate. Stimulus generalization occurred with the racemate and the R-(-) enantiomer of the alpha-methyl homologue and the S-(+) enantiomer of the alpha-ethyl primary amine. No generalization occurred with the other enantiomers or with the N-methyl derivatives of either series. Human psychopharmacology studies revealed that the N-methyl derivative of the title compound was nonhallucinogenic and that it had a new, novel psychoactive effect. It is suggested that this compound is the prototype of a new pharmacologic class that may have value in facilitating psychotherapy and that this class be designated as entactogens.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Animals
  • Butylamines / chemical synthesis*
  • Butylamines / pharmacology
  • Dioxoles / chemical synthesis*
  • Dioxoles / pharmacology
  • Discrimination Learning / drug effects
  • Female
  • Generalization, Stimulus / drug effects
  • Hallucinogens / pharmacology
  • Humans
  • Lysergic Acid Diethylamide / pharmacology
  • Male
  • Middle Aged
  • Psychotropic Drugs / chemical synthesis*
  • Psychotropic Drugs / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Structure-Activity Relationship

Substances

  • Butylamines
  • Dioxoles
  • Hallucinogens
  • Psychotropic Drugs
  • Lysergic Acid Diethylamide